Thursday, July 16, 2026

 

Beyond the lab: rapid mass spectrometry techniques charted for traditional Chinese medicine analysis



A comprehensive review in Biomedical Analysis assesses the current state and future of direct mass spectrometry for the quality control, safety, and authentication of herbal medicines, highlighting key successes and remaining challenges




Biomedical Analysis

Comprehensive framework of direct mass spectrometry for traditional Chinese medicine analysis 

image: 

Comprehensive overview of the direct mass spectrometry framework for TCM analysis, including platforms, applications, supportive data-analysis strategies, and future development trends.

view more 

Credit: Kaiwen Zhang, Bin Li & Chang-jiang-sheng Lai





Traditional Chinese Medicine (TCM) products contain highly complex mixtures of chemical components, making rapid and reliable quality assessment a major analytical challenge. A new review published in the journal Biomedical Analysis provides a comprehensive assessment of how direct mass spectrometry is being applied to address this challenge. Researchers from institutions including Tianjin University of Commerce have synthesized more than a decade of scientific literature to evaluate the technology’s current capabilities and future potential. The review examines how these rapid analytical techniques, which require little to no sample preparation, can provide immediate chemical insights into herbal products, from raw materials to finished decoctions.

A New Lens for Ancient Medicine

Analyzing TCM is notoriously difficult due to the immense chemical diversity and complexity of herbal materials, which change significantly during processing. The review summarizes how direct mass spectrometry techniques, such as ambient ionization, bypass time-consuming separation steps common in conventional analysis. This approach allows for the rapid generation of a chemical fingerprinting profile, the monitoring of chemical changes as they happen, and even the visualization of where specific compounds are located within plant tissues. This provides a more direct and context-rich picture of a sample's chemical makeup.

Watching Chemistry Happen in Real Time

The authors identify process monitoring and safety evaluation as particularly mature applications. The review consolidates findings from studies where researchers used direct mass spectrometry to track the transformation of compounds during the decoction (boiling) of herbs. A key example highlighted is the real-time monitoring of toxic alkaloids in Aconitum species. By observing how concentrations of these compounds decrease over time, the technology offers a dynamic way to ensure the safety and proper processing of potent herbal medicines, moving beyond simple before-and-after snapshots.

Bridging the Gap from Signal to Significance

Despite its speed and convenience, the review points out significant hurdles that prevent the technology's widespread adoption for all analytical tasks. The authors conclude from the literature that major bottlenecks remain in absolute quantification, where determining the exact amount of a substance is critical. Issues like matrix effects—interference from the complex background of the sample—and a lack of consistency between different laboratories currently limit its use for regulatory decision-making. The review also notes that the technology's performance is uneven across different chemical classes; it is highly effective for alkaloids but remains challenging for compounds like carbohydrates and polysaccharides.

The synthesis of existing research shows that the most developed and practical applications are in rapid fingerprinting for authentication and origin discrimination. These methods are already capable of quickly distinguishing between similar-looking herbs, identifying adulterants, and verifying the geographical source of a sample. This capability is approaching readiness for routine quality control in the herbal medicine industry, where speed and high throughput are essential.

Looking forward, the authors outline a path for advancing the field. Progress will depend less on developing new ionization techniques and more on standardizing existing methods to improve reliability and inter-laboratory comparability. The creation of dedicated, standardized spectral databases for TCM compounds is essential for more confident identification. The review also discusses the growing role of portable mass spectrometry for on-site testing and the use of artificial intelligence (AI) to help interpret the vast amounts of complex data produced by these methods.

Ultimately, the review presents a task-oriented roadmap for the application of direct mass spectrometry in TCM. It clarifies which analytical goals are already achievable—such as rapid screening and process monitoring—and which require further methodological refinement, including robust quantification and in-depth pharmacokinetic studies. The long-term goal is to evolve this powerful toolbox into a fully integrated evidence platform that connects rapid chemical analysis with the quality, safety, and efficacy of Traditional Chinese Medicine.

DOI: 10.1016/j.bioana.2026.05.001

Read the full article: https://doi.org/10.1016/j.bioana.2026.05.001

Call for Papers

Biomedical Analysis invites submissions for its 2026 Special Issue, “Biosensing and Nanoanalytical Technologies,” scheduled for publication in December 2026. The issue welcomes original research articles and reviews on innovative biosensing strategies, nanoanalytical technologies, functional nanomaterials, optical and electrochemical sensing, signal amplification, imaging, microfluidic and point-of-care platforms, and biomedical applications in disease diagnosis and precision medicine.

The submission deadline is September 30, 2026. Please refer to the Guide for Authors to prepare your manuscript and select the article type of ": “VSI: Biosensing and Nanoanalytical Technologies" when submitting your manuscript online. Submit your manuscript at: https://www2.cloud.editorialmanager.com/bioana/default2.aspx

About Biomedical Analysis

Biomedical Analysis is an international, peer-reviewed, open access journal published by Elsevier and KeAi and jointly sponsored by Sun Yat-sen University and the Guangzhou Analysis and Testing Center.

The journal publishes high-quality research in biomedical engineering, bioanalytical chemistry, biochemistry, genetics, biology, biomaterials, medicine, and related interdisciplinary fields, with a particular focus on biomedical testing, sensing technologies, and analytical innovation. Biomedical Analysis is indexed in Scopus, CAS, DOAJ, and EBSCO. Article processing charges (APCs) are currently waived for accepted manuscripts through the end of 2026.

Journal website: https://www.sciencedirect.com/journal/biomedical-analysis.

  

General workflow of direct mass spectrometry and comparison with LC-MS/GC-MS.

Credit

Kaiwen Zhang, Bin Li & Chang-jiang-sheng Lai

No comments: